GLOW LIFETECH CORP. Net Assets
GLOW LIFETECH CORP. net assets. Based on the latest financial reports, GLOW LIFETECH CORP. (9DO) has net assets worth €3.07 Million EUR (≈ $3.59 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.18 Million ≈ $4.89 Million USD) and total liabilities (€1.11 Million ≈ $1.30 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore GLOW LIFETECH CORP. annual equity growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €3.07 Million |
| % of Total Assets | 73.41% |
| Annual Growth Rate | -5.76% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 78.65 |
Net Assets of GLOW LIFETECH CORP. (2021–2025)
Net assets of GLOW LIFETECH CORP. from 2021 to 2025. This chart illustrates how GLOW LIFETECH CORP.'s net assets have evolved over time, based on quarterly financial data. See GLOW LIFETECH CORP. balance sheet quality to measure how much of total assets are equity-financed.
Annual Net Assets for GLOW LIFETECH CORP. (2021–2025)
The table below shows the annual net assets of GLOW LIFETECH CORP. from 2021 to 2025. For live market cap and overall valuation, see GLOW LIFETECH CORP. stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €2.71 Million ≈ $3.17 Million |
+5.42% |
| 2024-12-31 | €2.57 Million ≈ $3.01 Million |
+349.29% |
| 2023-12-31 | €-1.03 Million ≈ $-1.21 Million |
-185.04% |
| 2022-12-31 | €1.21 Million ≈ $1.42 Million |
-64.71% |
| 2021-12-31 | €3.44 Million ≈ $4.02 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to GLOW LIFETECH CORP.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 774186200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
GLOW LIFETECH CORP. Net Assets Breakdown (December 2025)
GLOW LIFETECH CORP. net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €21.77 Million | 803.25% |
| Total Equity | €2.71 Million | 100.00% |
GLOW LIFETECH CORP. Competitors by Market Cap
The table below lists competitors of GLOW LIFETECH CORP. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Franchise Brands PLC
LSE:FRAN
|
$3.66 Million |
|
Kandal M Venture Limited Class A Ordinary Shares
NASDAQ:FMFC
|
$3.66 Million |
|
YB Ventures Bhd
KLSE:5048
|
$3.67 Million |
|
Papyrus Australia Ltd
AU:PPY
|
$3.67 Million |
|
Megado Minerals Ltd
AU:MEG
|
$3.65 Million |
|
Highway Holdings Limited
NASDAQ:HIHO
|
$3.65 Million |
|
ZhongDe Waste Technology AG
F:ZEF
|
$3.65 Million |
|
Volcanic Gold Mines Inc
V:VG
|
$3.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GLOW LIFETECH CORP.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,570,389 to 2,709,731, a change of 139,342 (5.4%).
- Net loss of 617,861 reduced equity.
- Other factors increased equity by 757,203.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-617.86K | -22.8% |
| Other Changes | €757.20K | +27.94% |
| Total Change | €- | 5.42% |
Book Value vs Market Value Analysis
This analysis compares GLOW LIFETECH CORP.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.61x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.40x to 1.61x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.06 | €0.02 | x |
| 2022-12-31 | €0.02 | €0.02 | x |
| 2023-12-31 | €-0.02 | €0.02 | x |
| 2024-12-31 | €0.02 | €0.02 | x |
| 2025-12-31 | €0.01 | €0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GLOW LIFETECH CORP. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -22.80%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -30.09%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.45x
- Recent ROE (-22.80%) is above the historical average (-127.40%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -329.33% | 0.00% | 0.00x | 1.10x | €-11.66 Million |
| 2022 | -181.50% | 0.00% | 0.00x | 1.96x | €-2.32 Million |
| 2023 | 0.00% | -3617.40% | 0.03x | 0.00x | €-1.49 Million |
| 2024 | -103.38% | -317.79% | 0.22x | 1.45x | €-2.91 Million |
| 2025 | -22.80% | -30.09% | 0.52x | 1.45x | €-888.83K |
Industry Comparison
This section compares GLOW LIFETECH CORP.'s net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $165,369,067
- Average return on equity (ROE) among peers: -55.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GLOW LIFETECH CORP. (9DO) | €3.07 Million | -329.33% | 0.36x | $3.66 Million |
| TME PHARM.CONF.IPO EO 1- (0N6A) | $4.50 Million | -321.01% | 1.17x | $10.44 Million |
| PROQR THERAPEUTICS EO-04 (0PQ) | $88.56 Million | -31.35% | 0.90x | $142.34 Million |
| TIZIANA LIFE SCIENCES LTD (0RP) | $41.28 Million | -56.73% | 0.18x | $141.34 Million |
| Theravance Biopharma Inc (0TB) | $-51.59 Million | 0.00% | 0.00x | $828.57 Million |
| I-MAB SPONS.ADS/1 -0001 (0VY) | $715.33 Million | -51.14% | 0.23x | $141.97 Million |
| PreveCeutical Medical Inc (18H) | $-4.64 Million | 0.00% | 0.00x | $3.34 Million |
| Argen-X (1AE) | $63.37 Million | -33.73% | 0.67x | $41.67 Billion |
| GH RESEARCH PLC DL-025 (1KA) | $277.18 Million | -3.32% | 0.01x | $1.22 Billion |
| WAVE LIFE SCIENCES LTD. (1U5) | $518.36 Million | -39.43% | 0.23x | $714.18 Million |
| BIOCURE TECHNOLOGY INC. (1WH) | $1.34 Million | -19.58% | 0.49x | $960.84K |
About GLOW LIFETECH CORP.
Glow Lifetech Corp., an ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based capsules, and market-ready products, as well as precision-dosed capsules. The company has exclusive North American rights for the pr… Read more